Welcome to the Dewhurst Lab

Publications

• 1. Raymonda MH
  2. Ciesla JH
  3. Monaghan M
  4. Leach J
  5. Asantewaa G
  6. Smorodintsev-Schiller LA
  7. Lutz MM
  8. Schafer XL
  9. Takimoto T
  10. Dewhurst S
  11. Munger J
  12. Harris IS
  Pharmacologic profiling reveals lapatinib as a novel antiviral against SARS-CoV-2 in vitro.; Virology; Vol 566. 2021 Nov 27.
• 1. Sherby MR
  2. Kalb LG
  3. Coller RJ
  4. DeMuri GP
  5. Butteris S
  6. Foxe JJ
  7. Zand MS
  8. Freedman EG
  9. Dewhurst S
  10. Newland JG
  11. Gurnett CA
  Supporting COVID-19 School Safety for Children With Disabilities and Medical Complexity.; Pediatrics. 2021 Nov 04.
• 1. Chojnacki M
  2. Dobrotka C
  3. Osborn R
  4. Johnson W
  5. Young M
  6. Meyer B
  7. Laskey E
  8. Wozniak RAF
  9. Dewhurst S
  10. Dunman PM
  Evaluating the Antimicrobial Properties of Commercial Hand Sanitizers.; mSphere; Vol 6(2). 2021 Mar 03.
• 1. Cox A
  2. Schmierer J
  3. D'Angelo J
  4. Smith A
  5. Levenson D
  6. Treanor J
  7. Kim B
  8. Dewhurst S
  A Mutated PB1 Residue 319 Synergizes with the PB2 N265S Mutation of the Live Attenuated Influenza Vaccine to Convey Temperature Sensitivity.; Viruses; Vol 12(11). 2020 Oct 31.
• 1. Simpson SR
  2. Singh MV
  3. Dewhurst S
  4. Schifitto G
  5. Maggirwar SB
  Platelets function as an acute viral reservoir during HIV-1 infection by harboring virus and T-cell complex formation.; Blood advances; Vol 4(18). 2020 Sep 22.
• 1. Piekna-Przybylska D
  2. Bambara RA
  3. Maggirwar SB
  4. Dewhurst S
  G-quadruplex ligands targeting telomeres do not inhibit HIV promoter activity and cooperate with latency reversing agents in killing latently infected cells.; Cell cycle (Georgetown, Tex.). 2020 Aug 17.